7:30 am Registration
Optimizing Local Breast Cancer Treatment
Moderator: Joyce O’Shaughnessy
8:00 AM Introduction and Case Presentations
Joyce O’Shaughnessy
8:15 AM Morphofunctional Features of Breast Cancer and Choice of Therapy
Fattaneh Tavassoli
8:40 AM Sentinel Lymph Node Controversies
David Euhus
9:05 AM New Concepts/Techniques in Primary Breast Surgery
Monica Morrow
9:30 AM Adjuvant Chemotherapy for Elderly Patients
Hyman Muss
9:55 AM Break
10:15 AM MRI in Breast Cancer Management
Carol Lee
10:40 AM Clinical Utility of PET in Breast Cancer Management
David Mankoff
11:05 AM Prognostic and Predictive Factors of Clinical Importance
Claudine Isaacs
11:30 AM Panel Case Discussion
12:00 PM Lunch
State of the Art: Adjuvant Chemotherapy
Moderator Sandra Swain
1:00 PM Introduction and Case Presentations
1:15 PM Key Adjuvant Therapy Principles From the 2000 Oxford Overview
Rowan Chlebowski
1:40 PM Predicting Benefit From Adjuvant Therapy
Peter Ravdin
2:05 PM Chemotherapy for Low-Moderate-Risk Breast Cancer
Sandra Swain
2:30 PM Chemotherapy for High-Risk Breast Cancer
Clifford Hudis
2:55 PM Break
3:15 PM New Concepts in Adjuvant Chemotherapy
Joyce O’Shaughnessy
3:40 PM Managing Toxicity: Fatigue and Cognition
Hope Rugo
4:05 PM Managing Toxicity: Emesis, Neutropenia, and Anemia
Frankie Ann Holmes
4:30 PM Panel Case Discussion
5:00 PM Closing Remarks and Adjournment
5:00 PM Join Us for Our Wine & Cheese Welcome Reception


Saturday, October 25, 2003

7:30 am Registration
Breast Precancer: Diagnosis and Treatment
Moderator: Lori Pierce
8:00 AM Introduction and Case Presentations
8:15 AM Histologic and Biologic Characteristics of DCIS
Craig Allred
8:40 AM Treating Breast Intraepithelial Neoplasia
Carol Fabian
9:05 AM Identifying and Managing Genetic Risk: BRCA1/2 and Beyond
Judy Garber
9:30 AM Therapy of Rare Breast Cancers
David Euhus
9:55 AM Break
10:15 AM Partial Breast Irradiation: Who Is a Candidate?
Silvia Formenti
10:40 AM New Issues in Radiation Therapy Planning
Lori Pierce
11:05 AM Curative Local Radiotherapy: Who and Which Fields?
Eric Strom
11:30 AM Panel Case Discussion
12:00 PM Lunch
State of the Art: Adjuvant Hormonal Therapy
Moderator: Edith Perez
1:00 PM Introduction and Case Presentations
1:15 PM Optimal Hormonal Therapy for Premenopausal Patients
Edith Perez
1:40 PM Anastrozole Is Optimal Adjuvant Therapy for Postmenopausal Patients
William Gradishar
2:05 PM Counterpoint: It Is Not Yet Time to Abandon Tamoxifen as an Effective Adjuvant Hormonal Therapy
Julie Gralow
2:30 PM Adjuvant Treatment Considerations for HER2-Positive Breast Cancer
Andrew Seidman
ADJUVANT HORMONAL Therapy
Moderator: George Sledge
3:15 PM Adjuvant Bisphosphonate Therapy
Julie Gralow
3:40 PM Who Is Best Treated for Hormonal Therapy Alone?
George Sledge
4:05 PM Stage IV NED: Treatment Considerations
Lori Goldstein
4:30 PM Panel Case Discussion
5:00 PM Closing Remarks and Adjournment
 

Sunday, October 26, 2003

7:00 am Registration
Emerging Developments in Preoperative Therapy
Moderator: Eleftherios Mamounas
7:30 AM Small-Group Case Discussions With Faculty
8:30 AM Introduction and Case Presentations
Joyce O’Shaughnessy
8:45 AM Selection of Optimal Preoperative Chemotherapy Regimen Based on the Molecular Profile of Cancer
Lajos Pusztai
9:10 AM Sentinal Lymph Node Biopsy and Preoperative Chemotherapy: Timing and Clinical Utility
Eleftherios Mamounas
9:35 AM Trastuzumab With Preoperative Chemotherapy: The Emerging Standard?
Eric Winer
10:15 AM Biologic Agents With Promise for Breast Cancer
Mark Pegram
10:40 AM Complementary Therapies for Breast Cancer:What’s Promising?
Mitchell Gaynor
11:05 AM Rehabilitation After Adjuvant Therapy: Diet and Exercise
Anne McTiernan
11:30 AM New Hypotheses in Adjuvant Breast Cancer
Jeffrey Abrams
11:55 AM Panel Case Discussion
12:00 PM Lunch